GENTIBIO Trademark

Trademark Overview

On Monday, April 1, 2024, a trademark application was filed for GENTIBIO with the United States Patent and Trademark Office. The USPTO has given the GENTIBIO trademark a serial number of 98478168. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, January 6, 2025. This trademark is owned by GentiBio, Inc.. The GENTIBIO trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of pharmaceuticals and therapies, namely, drugs for autoimmune, alloimmune, and inflammatory diseases, for others; Custom manufacturing of biological cells; Consultation in the field of custom manufacture of pharmaceuticals, therapies, namely, drugs for autoimmune, alloimmune, and inflammatory diseases and biological cells

Pharmaceutical preparations for use in the treatment of autoimmune diseases and disorders, autoinflammatory diseases and disorders, alloimmune diseases and disorders, allergic diseases and disorders, autoimmune diseases and disorders, acute illness, diabetes, stroke, inflammation and inflammatory disease, respiratory and infectious diseases, acute respiratory distress illness, immunological disorders and metabolic diseases; Autologous therapies, namely, cells for medical purposes; Allogeneic therapies, namely, cells for medical purposes; Biological preparations for the treatment of cancer, namely, virotherapies; Human cells for medical purposes; Cells for medical therapy use; Cultured human cells for medical therapeutic use

Scientific research; Pharmaceutical and medical therapeutic research services; Medical research; Engineering of biological cells; Genetic engineering of biological cells; Technological consultation services in the fields of engineering of biological cells; Laboratory research services in the field of immunology and cellular engineering
gentibio

General Information

Serial Number98478168
Word MarkGENTIBIO
Filing DateMonday, April 1, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateMonday, January 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesCustom manufacture of pharmaceuticals and therapies, namely, drugs for autoimmune, alloimmune, and inflammatory diseases, for others; Custom manufacturing of biological cells; Consultation in the field of custom manufacture of pharmaceuticals, therapies, namely, drugs for autoimmune, alloimmune, and inflammatory diseases and biological cells
Goods and ServicesPharmaceutical preparations for use in the treatment of autoimmune diseases and disorders, autoinflammatory diseases and disorders, alloimmune diseases and disorders, allergic diseases and disorders, autoimmune diseases and disorders, acute illness, diabetes, stroke, inflammation and inflammatory disease, respiratory and infectious diseases, acute respiratory distress illness, immunological disorders and metabolic diseases; Autologous therapies, namely, cells for medical purposes; Allogeneic therapies, namely, cells for medical purposes; Biological preparations for the treatment of cancer, namely, virotherapies; Human cells for medical purposes; Cells for medical therapy use; Cultured human cells for medical therapeutic use
Goods and ServicesScientific research; Pharmaceutical and medical therapeutic research services; Medical research; Engineering of biological cells; Genetic engineering of biological cells; Technological consultation services in the fields of engineering of biological cells; Laboratory research services in the field of immunology and cellular engineering

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 1, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, April 1, 2024
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 1, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGentiBio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events

Event DateEvent Description
Monday, April 1, 2024NEW APPLICATION ENTERED
Wednesday, September 4, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 12, 2024ASSIGNED TO EXAMINER
Saturday, October 19, 2024NON-FINAL ACTION E-MAILED
Saturday, October 19, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, October 19, 2024NON-FINAL ACTION WRITTEN
Monday, January 6, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 6, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 6, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED

Related Keywords

gentibio cells diseases medical biological disorders namely research engineering autoimmune therapies